These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3730329)

  • 1. Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy.
    Jensen J; Nilas L; Christiansen C
    Br J Obstet Gynaecol; 1986 Jun; 93(6):613-8. PubMed ID: 3730329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women.
    Jensen J; Christiansen C
    Maturitas; 1987 Nov; 9(3):259-66. PubMed ID: 3323852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A continuous estrogen-progestogen regimen for climacteric complaints. Effects on lipid and lipoprotein metabolism.
    Mattsson LA; Cullberg G; Samsioe G
    Acta Obstet Gynecol Scand; 1984; 63(8):673-7. PubMed ID: 6524301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate.
    Owens D; Collins PB; Johnson A; Tomkin GH
    Diabet Med; 2000 Apr; 17(4):308-15. PubMed ID: 10821298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal women.
    Jensen J; Riis BJ; Strøm V; Christiansen C
    Br J Obstet Gynaecol; 1987 Feb; 94(2):130-5. PubMed ID: 3828253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment.
    Christiansen C; Christensen MS; Grande P; Transbøl I
    Maturitas; 1984 Mar; 5(3):193-9. PubMed ID: 6727693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
    Christiansen C; Riis BJ
    Br J Obstet Gynaecol; 1990 Dec; 97(12):1087-92. PubMed ID: 2126198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
    Hirvonen E; Mälkönen M; Manninen V
    N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
    Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
    Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on lipoproteins of Trisequens, a combined hormone preparation.
    Fletcher CD; Farish E; Hart DM; Leggate J; Clark DM; Kitchener H; Sharpe GL
    Maturitas; 1984 Nov; 6(3):279-83. PubMed ID: 6595494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate.
    Samsioe G; Li C; Borgfeldt C; Wilawan K; Aberg A; Larsen S
    Menopause; 2002; 9(5):335-42. PubMed ID: 12218722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
    Jensen J; Riis BJ; Strøm V; Christiansen C
    Maturitas; 1989 Jun; 11(2):117-28. PubMed ID: 2547137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial.
    Munk-Jensen N; Ulrich LG; Obel EB; Nielsen SP; Edwards D; Meinertz H
    Am J Obstet Gynecol; 1994 Jul; 171(1):132-8. PubMed ID: 8030688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-progestogen replacement in climacteric women, particularly as regards a new type of continuous regimen.
    Mattsson LA; Samsioe G
    Acta Obstet Gynecol Scand Suppl; 1985; 130():53-8. PubMed ID: 3859976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein and apolipoprotein levels in postmenopausal women on continuous oestrogen/progestogen therapy.
    Farish E; Fletcher CD; Dagen MM; Hart DM; Al-Azzawi F; Parkin DE; Howie CA
    Br J Obstet Gynaecol; 1989 Mar; 96(3):358-64. PubMed ID: 2713295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O; Lim P; Caubel P
    Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.